Ryvu advances romaciclib program as FDA clears AML trial expansion
The regulatory decision follows promising results from RIVER-81
The regulatory decision follows promising results from RIVER-81
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
The company says the goal is to improve consistency and efficiency in total hip arthroplasty (THA) as demand for the procedure continues to surge
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
At the center of deployment is mlHealth360’s proprietary Scaida AI platform, designed to detect and triage abnormalities in CT scans
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug (anticonvulsant) used for treatment of partial-onset seizures in patients 1 month of age and older
Subscribe To Our Newsletter & Stay Updated